Tokai Pharma Cmn (TKAI) 1.28 $TKAI APPROACHING
Post# of 273254
Posted On: 09/20/2016 11:07:56 AM
Tokai Pharma Cmn (TKAI) 1.28 $TKAI
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Sep 19, 1:07PM CDT
LOS ANGELES, CA / ACCESSWIRE / September 19, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tokai Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 30, 2016
BusinessWire - Mon Sep 19, 12:33PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tokai Pharmaceuticals, Inc. (TKAI) and Lead Plaintiff Deadline - September 30, 2016
ACCESSWIRE - Mon Sep 19, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / September 19, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against of Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI). The class is on behalf of a class consisting of all persons or entities who purchased Tokai from June 24, 2015 through July 25, 2016, inclusive (the "Class Period".
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tokai Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- TKAI
GlobeNewswire - Mon Sep 19, 9:00AM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ:TKAI) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-06106, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Tokai securities between June 24, 2015 and July 25, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
TKAI: 1.28 (-0.06)
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Fri Sep 16, 1:10PM CDT
IRVINE, CA / ACCESSWIRE / September 16, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Upcoming Deadline
GlobeNewswire - Fri Sep 16, 11:16AM CDT
Rigrodsky & Long, P.A.:
TKAI: 1.28 (-0.06)
IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 16, 11:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 16, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
TKAI ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 Deadline in Class Action - TKAI
GlobeNewswire - Fri Sep 16, 9:48AM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tokai Pharmaceuticals, Inc. securities (NASDAQ:TKAI) from June 24, 2015 through July 25, 2016, both dates inclusive (the "Class Period" of the important September 30, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tokai Pharmaceuticals investors under the federal securities laws.
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Thu Sep 15, 6:55PM CDT
IRVINE, CA / ACCESSWIRE / September 15, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
WeissLaw LLP Announces Class Action Lawsuit Against Tokai Pharmaceuticals, Inc.
PR Newswire - Thu Sep 15, 2:33PM CDT
WeissLaw LLP announces that a class action has been filed in the United States District Court for the Southern District of New York against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (TKAI) and certain Company officers, for among other things, violation of sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 (the "Exchange Act". The class action seeks to pursue remedies on behalf of all person or entities who purchased or otherwise acquired shares of Tokai between June 24, 2015 and July 25, 2016 (the "Class Period".
TKAI: 1.28 (-0.06)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Sep 15, 11:05AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 15, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
Scott + Scott, LLP Reminds Investors of September 30, 2016 Deadline in Tokai Pharmaceuticals, Inc. (TKAI) Securities Case, Encourages Investors to Contact Firm
GlobeNewswire - Thu Sep 15, 10:15AM CDT
Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that September 30, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq:TKAI). Tokai investors are encouraged to contact Scott + Scott at (646) 582-0121 or email jhalloran@scott-scott.com to discuss their legal rights.
TKAI: 1.28 (-0.06)
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Tue Sep 13, 2:14PM CDT
IRVINE, CA / ACCESSWIRE / September 13, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
TKAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tokai Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of September 30, 2016
BusinessWire - Tue Sep 13, 12:36PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc. (NASDAQGM: TKAI) securities between June 24, 2015 and July 25, 2016.
TKAI: 1.28 (-0.06)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Sep 12, 10:37AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 12, 2016 / Lundin Law PC (the "Firm" announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Tokai Pharmaceuticals, Inc. to Contact the Firm Before Lead Plaintiff Deadline
Marketwire Canada - Mon Sep 12, 9:43AM CDT
NEW YORK, NY--(Marketwired - September 12, 2016) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI) of the September 30, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
TKAI: 1.28 (-0.06)
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 09, 2:31PM CDT
IRVINE, CA / ACCESSWIRE / September 9, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline.
TKAI: 1.28 (-0.06)
INVESTOR ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 Deadline in Class Action - TKAI
PR Newswire - Fri Sep 09, 12:16PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tokai Pharmaceuticals, Inc. securities (NASDAQ: TKAI) from June 24, 2015 through July 25, 2016, both dates inclusive (the "Class Period" of the important September 30, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tokai Pharmaceuticals investors under the federal securities laws.
TKAI: 1.28 (-0.06)
TKAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Tokai Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of September 30, 2016
PR Newswire - Fri Sep 09, 8:52AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc. (NASDAQGM: TKAI) securities between June 24, 2015 and July 25, 2016.
TKAI: 1.28 (-0.06)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Mon Sep 19, 1:07PM CDT
LOS ANGELES, CA / ACCESSWIRE / September 19, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tokai Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 30, 2016
BusinessWire - Mon Sep 19, 12:33PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tokai Pharmaceuticals, Inc. (TKAI) and Lead Plaintiff Deadline - September 30, 2016
ACCESSWIRE - Mon Sep 19, 9:23AM CDT
NEW YORK, NY / ACCESSWIRE / September 19, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against of Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company"
(NASDAQ: TKAI). The class is on behalf of a class consisting of all persons or entities who purchased Tokai from June 24, 2015 through July 25, 2016, inclusive (the "Class Period". TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tokai Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- TKAI
GlobeNewswire - Mon Sep 19, 9:00AM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company"
(NASDAQ:TKAI) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 16-cv-06106, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Tokai securities between June 24, 2015 and July 25, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". TKAI: 1.28 (-0.06)
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Fri Sep 16, 1:10PM CDT
IRVINE, CA / ACCESSWIRE / September 16, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Upcoming Deadline
GlobeNewswire - Fri Sep 16, 11:16AM CDT
Rigrodsky & Long, P.A.:
TKAI: 1.28 (-0.06)
IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 16, 11:01AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 16, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
TKAI ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 Deadline in Class Action - TKAI
GlobeNewswire - Fri Sep 16, 9:48AM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tokai Pharmaceuticals, Inc. securities (NASDAQ:TKAI) from June 24, 2015 through July 25, 2016, both dates inclusive (the "Class Period"
of the important September 30, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tokai Pharmaceuticals investors under the federal securities laws. TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Thu Sep 15, 6:55PM CDT
IRVINE, CA / ACCESSWIRE / September 15, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
WeissLaw LLP Announces Class Action Lawsuit Against Tokai Pharmaceuticals, Inc.
PR Newswire - Thu Sep 15, 2:33PM CDT
WeissLaw LLP announces that a class action has been filed in the United States District Court for the Southern District of New York against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company"
(TKAI) and certain Company officers, for among other things, violation of sections 10(b) and 20(a) of the Securities and Exchange Act of 1934 (the "Exchange Act". The class action seeks to pursue remedies on behalf of all person or entities who purchased or otherwise acquired shares of Tokai between June 24, 2015 and July 25, 2016 (the "Class Period". TKAI: 1.28 (-0.06)
APPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Sep 15, 11:05AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 15, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
Scott + Scott, LLP Reminds Investors of September 30, 2016 Deadline in Tokai Pharmaceuticals, Inc. (TKAI) Securities Case, Encourages Investors to Contact Firm
GlobeNewswire - Thu Sep 15, 10:15AM CDT
Scott + Scott, Attorneys at Law, LLP, a global investor rights law firm, reminds investors that September 30, 2016 is the last day to file lead plaintiff papers in the securities lawsuit against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company"
(Nasdaq:TKAI). Tokai investors are encouraged to contact Scott + Scott at (646) 582-0121 or email jhalloran@scott-scott.com to discuss their legal rights. TKAI: 1.28 (-0.06)
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm
ACCESSWIRE - Tue Sep 13, 2:14PM CDT
IRVINE, CA / ACCESSWIRE / September 13, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
TKAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tokai Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of September 30, 2016
BusinessWire - Tue Sep 13, 12:36PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc. (NASDAQGM: TKAI) securities between June 24, 2015 and July 25, 2016.
TKAI: 1.28 (-0.06)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Sep 12, 10:37AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 12, 2016 / Lundin Law PC (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (Nasdaq: TKAI) concerning possible violations of federal securities laws between June 24, 2015 and July 25, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm before the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Tokai Pharmaceuticals, Inc. to Contact the Firm Before Lead Plaintiff Deadline
Marketwire Canada - Mon Sep 12, 9:43AM CDT
NEW YORK, NY--(Marketwired - September 12, 2016) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company"
(NASDAQ: TKAI) of the September 30, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. TKAI: 1.28 (-0.06)
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 09, 2:31PM CDT
IRVINE, CA / ACCESSWIRE / September 9, 2016 / Khang & Khang LLP (the "Firm"
announces a class action lawsuit has been filed against Tokai Pharmaceuticals, Inc. ("Tokai" or the "Company" (NASDAQ: TKAI). Investors who purchased or otherwise acquired shares between June 24, 2015 and July 25, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 30, 2016 lead plaintiff motion deadline. TKAI: 1.28 (-0.06)
INVESTOR ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 Deadline in Class Action - TKAI
PR Newswire - Fri Sep 09, 12:16PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tokai Pharmaceuticals, Inc. securities (NASDAQ: TKAI) from June 24, 2015 through July 25, 2016, both dates inclusive (the "Class Period"
of the important September 30, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tokai Pharmaceuticals investors under the federal securities laws. TKAI: 1.28 (-0.06)
TKAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Tokai Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of September 30, 2016
PR Newswire - Fri Sep 09, 8:52AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Tokai Pharmaceuticals, Inc. (NASDAQGM: TKAI) securities between June 24, 2015 and July 25, 2016.
TKAI: 1.28 (-0.06)
(0)
(0)Scroll down for more posts ▼